Heart failure predominantly affects individuals of advanced age, and is currently reaching epidemic proportions. Nearly half the patients with symptoms of heart failure have preserved systolic ejection fraction (EF>50 percent), and are generally thought to suffer from ventricular diastolic dysfunction. However, most of these same individuals are over 65 years of age and have systolic hypertension, both factors that can themselves adversely impact on diastolic function. An additional mechanism that may prominently contribute to failure symptoms despite preservation of EF is ventricular-arterial stiffening. Vascular stiffening is common with aging, and results in increased arterial pulse pressure and systolic hypertension, both dominant risk factors for the development of coronary artery disease and heart failure. We have shown that ventricular systolic stiffening with or without cardiac hypertrophy accompanies progressive vascular stiffening with age. When combined, these changes can limit cardiac reserve capacity, enhance blood pressure fluctuations with daily activities of living, and limit coronary flow reserve. The studies in this proposal test the novel hypothesis that ventricular-vascular stiffening is a potent contributor to cardiac failure with preserved EF by reducing exercise capacity due to limited systolic reserve, enhancing blood pressure lability, and inducing abnormal coronary flow and myocardial energy balance with increased stress. The studies employ new methods for non-invasive quantitation of ventricular/vascular stiffening recently developed and validated in the P.I.'s laboratory. The first two specific aims test whether ventricular-vascular stiffening is greater in patients with """"""""non-systolic"""""""" heart failure versus a control group of similar age, blood pressure, hypertrophy, and sex, and tests its impact on blood pressure lability, reduced systolic reserve, and exercise performance.
The third aim focuses on the impact of ventricular/vascular stiffening on coronary flow regulation and high energy phosphate metabolism. These studies test the influence of combined stiffening on cardiac supply/demand balance with stress. This research should provide major new insights regarding the pathophysiology of heart failure with preserved EF and specifically the importance of ventricular-vascular stiffening. This could lead to new therapeutic approaches to this difficult clinical problem that affects a growing aged patient population.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG018324-04
Application #
6921487
Study Section
Special Emphasis Panel (ZRG1-CCVS (01))
Program Officer
Eldadah, Basil A
Project Start
2002-08-15
Project End
2007-07-31
Budget Start
2005-08-01
Budget End
2007-07-31
Support Year
4
Fiscal Year
2005
Total Cost
$442,836
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Borlaug, Barry A; Kass, David A (2009) Invasive hemodynamic assessment in heart failure. Heart Fail Clin 5:217-28
Moens, An L; Leyton-Mange, Jordan S; Niu, Xiaolin et al. (2009) Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor. J Mol Cell Cardiol 47:576-85
Moens, An L; Takimoto, Eiki; Tocchetti, Carlo G et al. (2008) Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy. Circulation 117:2626-36
Moens, An L; Champion, Hunter C; Claeys, Marc J et al. (2008) High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury. Circulation 117:1810-9
Borlaug, Barry A; Kass, David A (2008) Ventricular-vascular interaction in heart failure. Heart Fail Clin 4:23-36
Borlaug, Barry A; Melenovsky, Vojtech; Redfield, Margaret M et al. (2007) Impact of arterial load and loading sequence on left ventricular tissue velocities in humans. J Am Coll Cardiol 50:1570-7
Li, Manxiang; Chiou, Kuan-Rau; Kass, David A (2007) Shear stress inhibition of H(2)O(2) induced p66(Shc) phosphorylation by ASK1-JNK inactivation in endothelium. Heart Vessels 22:423-7
Kass, David A; Takimoto, Eiki; Nagayama, Takahiro et al. (2007) Phosphodiesterase regulation of nitric oxide signaling. Cardiovasc Res 75:303-14
Kass, David A; Champion, Hunter C; Beavo, Joseph A (2007) Phosphodiesterase type 5: expanding roles in cardiovascular regulation. Circ Res 101:1084-95
Kass, David A (2007) Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3? Circulation 116:233-5

Showing the most recent 10 out of 27 publications